Directorate Change

GUS PLC
29 November 2004

                                    GUS plc

                               Board Appointment

GUS plc, the retail and business services group, is pleased to announce that
John Coombe, currently Chief Financial Officer and director of GlaxoSmithKline
plc, will join its Board as a non-executive director on 1 April 2005.


Sir Victor Blank, Chairman of GUS, commented:

'I am very pleased to welcome John to GUS. He has wide ranging experience of
successful growth on an international scale which, when combined with his
knowledge of business and regulatory issues, makes him a very well-suited
addition to our Board.'

John Coombe said:

'GUS has made great progress over recent years and I believe the outlook for its
businesses is very exciting. I am delighted to be joining the Board.'


John Coombe is a member of the Supervisory Board of Siemens AG.

In accordance with the Listing Rules, GUS confirms that there are no matters
relating to John Coombe that would require disclosure under paragraph 6.F.2 (b)
to (g).



Enquiries:


Finsbury                                                           020 7251 3801

Rupert Younger
Rollo Head

***********************************************************

Notes to Editors:

John Coombe, 59, joined Glaxo in 1986 as Group Financial Controller and was
appointed Finance Director in 1992. He continued as Finance Director of Glaxo
through its transformational mergers with Wellcome and Smithkline Beecham. He
assumed the role of Chief Financial Officer for GlaxoSmithKline ('GSK') in
December 2000. John will retire from GSK on 31 March 2005.

Prior to joining Glaxo, John was Finance Manager at Charter Consolidated from
1984-1986 and Treasurer at Charterhouse from 1973-1984.


John is a former Chairman of the Hundred Group of Finance Directors and was a
member of the Accounting Standards Board for seven years. He is currently on the
Code Committee of the Takeover Panel and is a Trustee of the Royal Academy of
Arts.







                      This information is provided by RNS
            The company news service from the London Stock Exchange